View Older Stories View More Recent Stories
-
The Trade Desk Q1 preview: Here's why RBC analysts are expecting a ‘solid start’
-
Temple & Webster Group Ltd (TPW:AU) PT Raised to AUD20 at RBC Capital
-
RBC Capital Upgrades Pandora A/S (PNDORA:DC) (PANDY) to Sector Perform
-
Brewer AB InBev's profit surges ahead of forecasts, shares rise
-
NOVAGOLD Prices $179 Million Underwritten Upsized Public Offering of Common Shares
-
RBC Capital Upgrades AG Growth International Inc (AFN:CN) (AGGZF) to Outperform
-
RBC Capital Upgrades Mosaic (MOS) to Outperform
-
Aspen Announces Pricing of Upsized Initial Public Offering
-
Orchid Island Capital Announces May 2025 Monthly Dividend and April 30, 2025 RMBS Portfolio Characteristics
-
Kinetik Reports First Quarter 2025 Financial and Operating Results
-
Summit Midstream Corporation Reports First Quarter 2025 Financial and Operating Results
-
Sitio Royalties Reports First Quarter 2025 Operational and Financial Results
-
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
-
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
-
Xencor Reports First Quarter 2025 Financial Results
-
Westlake Chemical (WLK) PT Lowered to $96 at RBC Capital on 'PEM Weakness'
-
Qualys (QLYS) PT Raised to $140 at RBC Capital; 'Good Results vs Low Expectations'
-
Mercury Systems (MRCY) PT Raised to $50 at RBC Capital, Citing 'Steady Progress'
-
Sarepta Therapeutics (SRPT) PT Lowered to $58 at RBC Capital as 'Elevidys Hits A Wall'
-
Leidos Holdings (LDOS) PT Raised at RBC Capital as 'Strong 1Q25 Supports Improved Outlook'
-
'Jacobs Engineering Group Inc. (J) Positioned for H2 Improvement'; PT Raised at RBC Capital
-
RBC Capital Reiterates Outperform Rating on DoorDash Inc. (DASH)
-
'AECOM Technology (ACM) Continuing to Execute'; PT Raised to $126 at RBC Capital
-
RBC Capital Expects 'Strong' Print from Monster Beverage (MNST)
-
Repligen Corporation to Present at Upcoming May Investor Conferences
-
Arrowhead Pharmaceuticals to Participate in May 2025 Investor Conferences
-
RBC Capital Downgrades BioMerieux (BIM:FP) (BMXMF) to Sector Perform
-
Pandora Q1 earnings preview: 'Consensus estimates not reflecting FY26E commodity price pressure'
-
TWO Announces Pricing of Public Offering of Senior Notes
-
NOVAGOLD Announces Proposed Public Offering of Common Shares
-
AvidXchange Holdings (AVDX) Agrees to be Acquired by TPG in Partnership with Corpay for $2.2 Billion, $10 Per Share
-
AvidXchange Agrees to be Acquired by TPG in Partnership with Corpay for $2.2 Billion
-
American Homes 4 Rent (AMH) Prices $650M Notes Offering
-
American Homes 4 Rent Announces Pricing of Public Offering of $650 Million of 4.950% Senior Notes due 2030
-
Tandem Diabetes Care Announces Upcoming Conference Presentations
-
89bio to Participate in Upcoming Investor Conferences
-
US FDA names agency critic Vinay Prasad as top vaccine official
-
Tracy Robinson to Address the 2025 RBC Capital Markets Canadian Industrials Conference on May 14
-
Addus HomeCare to Participate in Upcoming Investor Conferences in May
-
'ServiceNow (NOW) Remains a Top Idea'; PT Raised to $1,100 at RBC Capital
-
RBC Capital on Palantir Technologies Inc. (PLTR): 'Solid Quarter, but a Commercial Miss'
-
Neurocrine Bio. (NBIX) PT Raised to $145 at RBC Capital Following 'Surprising Commercial Momentum'
-
RBC Capital on Inspire Medical Systems (INSP): 'Strong Start to 2025 With Inspire V Launch Potential'
-
BioCryst Pharma (BCRX) PT Raised to $13 at RBC Capital; 'Strong Out of the Gate in 2025'
-
RBC Capital Reiterates Outperform Rating on Walmart (WMT)
-
RBC Capital on Primo Brands Corp. (PRMB): 'Expect Fundamentals to Shine Through Despite Noise'
-
Banzai International (BNZI) Secures Expanded Agreement with RBC Capital Markets for OpenReel Enterprise License
-
Banzai Secures Expanded Agreement with RBC Capital Markets for OpenReel Enterprise License
-
RBC on Ferrari (RACE), 'investors were hoping for a guidance upgrade'
-
Puma SE (PUM:GR) (PMMAF) PT Lowered to EUR25 at RBC Capital
